A detailed history of New Covenant Trust Company, N.A. transactions in Eli Lilly & CO stock. As of the latest transaction made, New Covenant Trust Company, N.A. holds 3,203 shares of LLY stock, worth $2.32 Million. This represents 2.72% of its overall portfolio holdings.

Number of Shares
3,203
Previous 3,033 5.61%
Holding current value
$2.32 Million
Previous $2.6 Billion 8.11%
% of portfolio
2.72%
Previous 2.99%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$772.14 - $960.02 $131,263 - $163,203
170 Added 5.61%
3,203 $2.81 Billion
Q2 2024

Jul 30, 2024

SELL
$724.87 - $909.04 $177,593 - $222,714
-245 Reduced 7.47%
3,033 $2.6 Billion
Q1 2024

May 14, 2024

BUY
$592.2 - $792.28 $1.94 Million - $2.6 Million
3,278 New
3,278 $2.55 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $690B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track New Covenant Trust Company, N.A. Portfolio

Follow New Covenant Trust Company, N.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Covenant Trust Company, N.A., based on Form 13F filings with the SEC.

News

Stay updated on New Covenant Trust Company, N.A. with notifications on news.